Biohaven Ltd.
BHVN
Jodie situation report
Biohaven Ltd.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
- BHVN's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if BHVN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind BHVN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
REGNRegeneron Pharmaceuticals, Inc.partnerNov 10, 2025 ▾
“39 Table of Contents • Antibody Drug Conjugates ◦ BHV-1510 Phase 1/2 study in epithelial tumors: In May 2025, we reported further preliminary data from the study, where BHV-1510 demonstrated encouraging early clinical activity in combination with Regeneron's…”
Depended on by
CLYMClimb Bio, Inc.competitorMay 7, 2026 ▾
“In addition, companies targeting CD38, such as Biogen Inc.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
BHVN is currently a Follower in the organic co-movement group Energy Infrastructure & Biotech. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for BHVN; it is not active in the latest market snapshot.